The Reed Smith Life Sciences Health Industry Group will be hosting a free CLE webinar, "Where Was This Made? Country-of-Origin Issues for Pharmaceutical & Medical Device Companies," on July 19, 2016 at 12 p.m. ET. Drug and device manufacturers often struggle to correctly determine their products' "country of origin" thanks to ever-changing global supply chains and the fact that different government agencies employ entirely different legal standards. As a result, a product's country of origin may vary based on which agency is requiring a determination. This has caused considerable confusion and, yet, compliance has never been more important as multi-million dollar False Claims Act actions become more frequent for companies that incorrectly certify the origin of their products to the government.
In this webinar, Reed Smith presenters Jeffrey Orenstein and Lawrence Sher will be examining the numerous regulatory requirements that companies must take into consideration to ensure compliance over time. They will also be explaining the risks of non-compliance in the context of both administrative penalties and False Claims Act actions initiated by the government and whistleblowers.
This webinar is approved for 1 hour of general CLE credit in CA, IL, NJ, PA, TX and WV. To register for the free webinar, please click here.
This article is presented for informational purposes only and is not intended to constitute legal advice.
